# FDA Inspection 1196585 - Octapharma Plasma Inc - February 02, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/c73a4365-7d59-4318-a0ab-1dc4c8ead771
Source feed: FDA_Inspections

> FDA Inspection 1196585 for Octapharma Plasma Inc on February 02, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1196585
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-02-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1196585 - 2023-02-02](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e809e028-ce1e-48a6-ac9b-87d2d1c033a1)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/a51b21d1-afc2-470c-b51e-24e60bd96fc2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d